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Activity-dependent CREB phosphorylation and gene
expression are critical for long-term neuronal plas-
ticity. Local signaling at CaV1 channels triggers these
events, but how information is relayed onward to the
nucleus remains unclear. Here, we report a mecha-
nism that mediates long-distance communication
within cells: a shuttle that transports Ca2+/calmodulin
from the surface membrane to the nucleus. We show
that the shuttle protein is gCaMKII, its phosphoryla-
tion at Thr287 by bCaMKII protects the Ca2+/CaM
signal, and CaN triggers its nuclear translocation.
Both bCaMKII and CaN act in close proximity to
CaV1 channels, supporting their dominance, whereas
gCaMKII operates as a carrier, not as a kinase. Upon
arrival within the nucleus, Ca2+/CaM activates
CaMKK and its substrate CaMKIV, the CREB kinase.
This mechanism resolves long-standing puzzles
about CaM/CaMK-dependent signaling to the nu-
cleus. The significance of the mechanism is empha-
sized by dysregulation of CaV1, gCaMKII, bCaMKII,
and CaN in multiple neuropsychiatric disorders.
INTRODUCTION
Enduring neuronal plasticity requires communication between
surface electrical events and nuclear gene expression (Deisseroth
et al., 2003; Dolmetsch et al., 2001; Lonze and Ginty, 2002). Such
‘‘excitation-transcription (E-T) coupling’’ is exemplified by activity-
dependent regulation of the transcription factor cAMP-response
element binding protein (CREB), which is functionally important
for learning and memory (Bartsch et al., 1998; Impey et al.,
1996; Kandel, 2001; Yin et al., 1995). In mammalian neurons,
this signaling is potently initiated by Ca2+ influx through surface
CaV1 (L-type) channels (Greenberg et al., 1986; Morgan and
Curran, 1986; Murphy et al., 1991), but culminates micrometers
awaywith activation of nuclearCREB (Deisseroth et al., 1996; Dol-
metsch et al., 2001). Despite much study, basic questions persist
about mechanisms that link neuronal activity to nuclear events.Ca2+ binding to calmodulin (CaM) and consequent activation of
Ca2+/CaM-dependent protein kinases (Hudmon and Schulman,
2002; Kennedy, 2000) helps support E-T coupling (Wheeler
et al., 2008, 2012; Wu et al., 2001). The CaM kinase family is
most famous for aCaMKII, which contributes strongly to synaptic
potentiation, learning, and memory (Giese et al., 1998; Lisman
et al., 2002; Malinow et al., 1989; Silva et al., 1992; Wayman
et al., 2008). Together with bCaMKII, aCaMKII participates in E-T
coupling by gathering in signaling clusters within CaV1 channel
nanodomains (Wheeler et al., 2008, 2012). Additional CaM ki-
nases, CaMKIV andCaMKK, form aCaMKcascadewithin the nu-
cleus (Means, 2000; Soderling, 1999). Neuronal activity and Ca2+/
CaMdriveCaMKK tophosphorylate andactivatenuclearCaMKIV,
which phosphorylates CREB (Bito et al., 1996) and CREB-binding
protein (CBP) (Impey et al., 2002), thus triggering gene expression.
CaMK actions near the surface and within the nucleus are clearly
distinct, but the link between these remains unclear.
This article features another CaMK family member, gCaMKII,
which is enriched in mammalian brain, but also expressed in
heart, smooth muscle, liver, and immune cells (Bayer et al.,
1999; Gangopadhyay et al., 2003; Tobimatsu and Fujisawa,
1989). Variations in its gene (CAMK2G) are associated with unre-
liable memory (de Quervain and Papassotiropoulos, 2006) and
mental retardation (de Ligt et al., 2012). Here, we show that
gCaMKII provides a conduit between Ca2+ entry at the neuronal
surface and nuclear transcriptional events. gCaMKII operates
as a vectorial transporter of sequestered Ca2+/CaM, indepen-
dent of any catalytic activity. Once delivered to the nucleus by
gCaMKII, Ca2+/CaM triggers a highly cooperative activation of
the nuclear CaMK cascade, rapid phosphorylation of CREB,
and transcription of target genes. Our experiments demonstrate
that the gCaMKII shuttle is a long-sought mechanism to rapidly
link voltage-gated opening of CaV1 Ca
2+ channels to activity-
dependent transcription.
RESULTS
Changes in Spatial Distribution of gCaMKII upon
Stimulation
Studies in cultured superior cervical ganglion (SCG) neurons indi-
cated that E-T coupling is initiated in nanodomains just beneath
the plasmamembrane and involves clustering of CaMKII (a and bCell 159, 281–294, October 9, 2014 ª2014 Elsevier Inc. 281
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Figure 1. gCaMKII Translocates to the Nucleus in an Activity-Dependent Manner and Is Critical for E-T Coupling
(A) SCG neurons were stimulated at 10 Hz for 60 s or exposed to 40 mM K+ for 300 s and stained with a gCaMKII antibody. Scale bar represents 10 mm.
(B) Increase in nuclear: cytoplasmic ratio of gCaMKII intensity resulting from stimulation at 10 Hz for 60 s (solid bar) or from exposure to 40 mMK+ for 300 s (open
bar). Inset, recorded action potentials evoked by 10 Hz field stimulation.
(C) gCaMKII translocation triggered by 40 mM K+ stimulation was abolished by the CaV1-specific blocker Nim (10 mM).
(D1) mGFP-gCaMKII translocation upon 40 mM K+ stimulation. The bright field image indicates the cell shape, and other panels show epifluorescent images
(union jack format) captured at indicated time points.
(D2) Nuclear mGFP intensity, before and during 40 mM K+ stimulation (onset, t = 0 s, n = 4).
(E) SCG neurons expressing gCaMKII shRNA or nonsilencing control shRNAwere stimulatedwith 40mMK+ for 10 s and stained for pCREB (red). GFP (green) was
used to confirm expression of plasmids. The pCREB response was prevented by gCaMKII knockdown and rescued by overexpressing the shRNA-resistant
gCaMKII construct gCaMKIIR (see Figures S1H–S1J for details).
(legend continued on next page)
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isoforms) near CaV1 channels (Wheeler et al., 2008, 2012). These
findings explained the reliance of E-T coupling on CaV1 channels
but left open how a local aggregation of CaMKII at the surface
causes signaling to the nucleus. Neither aCaMKII nor bCaMKII
showed nuclear translocation following K+-depolarization, as in
hippocampal neurons (Deisseroth et al., 1998); this also held
for dCaMKII (Figures S1A–S1C available online). However, the
distribution of the gCaMKII underwent an 2.5-fold increase in
the nuclear: cytoplasmic intensity ratio upon depolarization
with 40 mM K+, due to elevated nuclear intensity and diminished
cytoplasmic intensity (Figures 1A and S1D). Similar changes
were evoked by trains of spikes (10 Hz field stimulation) (Fig-
ures 1A and 1B). The depolarization-induced translocation of
gCaMKII to the nucleus was abolished by nimodipine (Nim) (Fig-
ure 1C), a CaV1-specific channel blocker, indicating that CaV1
channels initiated the movement. To monitor the translocation
in real time, we expressed a monomeric GFP-tagged gCaMKII.
The GFP-gCaMKII fluorescence intensity consistently rose in
the nucleus upon stimulation (Figures 1D1 and 1D2) and progres-
sively decreased in the distal dendrites (Figures S1E and S1F),
consistent with translocation of tagged gCaMKII.
gCaMKII Is Critical for Rapid CREB Phosphorylation
and Gene Transcription
To find out whether gCaMKII is required for E-T coupling, we
studied the pCREB response following knockdown of gCaMKII,
performed with a lentivirus expressing short hairpin RNA
(shRNA) specific to gCaMKII. Stimulation by exposure to
40 mM K+ for 10 s gave a robust but nonsaturating pCREB
response (Figure S1G). Importantly, this pCREB response was
strongly attenuated by gCaMKII knockdown, but completely
rescued by cotransfecting gCaMKII cDNA that is resistant to
gCaMKII shRNA (indicated as gCaMKIIR; Figures 1E and S1H–
S1J). Furthermore, the sustained increase of CREB phosphory-
lation evoked by a 5 min depolarization was similarly abolished
by gCaMKII knockdown (Figure S1K), while the Ca2+ rise was
not reduced (Figure S1L). Thus, regardless of whether stimuli
were brief or prolonged, gCaMKII contributed to Ca2+-triggered
CREB phosphorylation.
To examine effects of gCaMKII on transcription, we tracked
the CREB-dependent gene c-fos (Sheng et al., 1990). Depolariz-
ing neurons with 40 K+ for 5 min led to an 2-fold increase in c-
fos levels (protein, Figure 1F; mRNA, Figure S1M). Strikingly, this
increase in gene expression was prevented by gCaMKII knock-
down and rescued by gCaMKIIR (Figures 1F and S1M). Thus
gCaMKII plays a critical role in supporting pCaMKII and CaM
redistribution to the nucleus and in driving CREB phosphoryla-
tion and gene expression.
Redistribution of Phospho-CaMKII upon Stimulation
Like other CaMKIIs, gCaMKII is regulated by phosphorylation at
a particular threonine (a: Thr286; b, g, and d: Thr287) (Hudmon
and Schulman, 2002; Kennedy, 2000). Finding that gCaMKII is(F) c-fos protein levels in SCG neurons transduced as in (E) and stimulated with 4
allow time for gene expression. gCaMKII knockdown prevented the expression of
all figures, the asterisk (*) denotes p < 0.001, as determined by Student’s t test.
See also Figure S1.critical for CREB phosphorylation led us to ask whether gCaMKII
translocates to the nucleus in a Thr287-phosphorylated state.
We used an antibody specific for phospho-Thr286/287 CaMKII
(pCaMKII) (not specific to any particular isoform) and compared
the distributions of gCaMKII and pCaMKII. Indeed, pCaMKII
immunostaining revealed a clear nuclear redistribution in neu-
rons subjected to field stimulation or 40 mM K+ (Figures 2A,
2B, S2A, and S2B). Like gCaMKII translocation, redistribution
of pCaMKII in response to 40mMK+ was prevented by Nim (Fig-
ures S2C and S2D).
A strong correlation was found between depolarization-driven
pCaMKII and gCaMKII redistributions across a population of
neurons (Figures 2C and S2E). A simple interpretation is that
gCaMKII translocated into the nucleus in a phospho-Thr287
form. We tested this by knocking down gCaMKII with shRNA
and found that the depolarization-dependent alteration in pCaM-
KII distribution was largely abolished (Figure 2D), indicating that
pCaMKII redistribution was dominated by nuclear translocation
of phosphorylated gCaMKII.
CaM Redistribution Correlates with the Translocation
of gCaMKII
One consequence of CaMKII autophosphorylation at Thr286/
287 is a >1,000-fold increase in the affinity of CaMKII for Ca2+/
CaM (Meyer et al., 1992). Thus, phosphorylated CaMKII might
sequester Ca2+/CaM long after cytosolic Ca2+ had subsided
(Deisseroth et al., 1998; Ma et al., 2012; Mermelstein et al.,
2001). We next asked whether phospho-gCaMKII and CaM
might travel to the nucleus together, in line with the proposed
role of CaM redistribution in E-T coupling (Deisseroth et al.,
1998; Mermelstein et al., 2001). We costained neurons for CaM
and gCaMKII after 40 K+ stimulation (Figure S2F). The ratios of
nuclear: cytoplasmic intensities for CaM and gCaMKII were
highly correlated (Figure 2E). Similarly, correlation was found
by directly comparing CaM translocation and pCaMKII redistri-
bution (Figures S2G and S2H). Knockdown of gCaMKII with
shRNA eliminated the stimulation-dependent increase in nu-
clear: cytoplasmic ratio of CaM staining seen with control shRNA
(Figure 2F). These results suggested that gCaMKII translocated
to the nucleus in a T287-phosphorylated form, accompanied
by CaM. This would account for the reciprocal changes in nu-
clear and cytoplasmic levels of pCaMKII and CaM. Finally, the
necessity of T287 phosphorylation was probed by an shRNA-
resistant construct (gCaMKIIR) encoding gCaMKII with Thr287
mutated to Ala (gCaMKIIR T287A). With endogenous gCaMKII
knocked down, ‘‘wild-type’’ gCaMKIIR fully rescued CaM trans-
location (Figures 2G, left, S2I, and S2J). In contrast, gCaMKIIR
T287A was unable to rescue CaM translocation even though it
translocated to the nucleus just as well as gCaMKIIR (Figures
2G, right, S2I, and S2J). Taken together, these results suggest
that gCaMKII carries CaM into the nucleus because Thr287
phosphorylation engages CaM trapping (Hudmon and Schul-
man, 2002; Meyer et al., 1992).0 mM K+ for 300 s, followed by 40 min incubation in normal culture medium to
c-fos, whichwas rescued by overexpressed gCaMKIIR (see also Figure S1M). In
Data are represented as mean ± SEM.
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Figure 2. Activity-Dependent Nuclear
pCaMKII Redistribution Is Driven by
gCaMKII/CaM Translocation
(A) SCG neurons were stimulated at 10 Hz for 60 s
or with 40 mM K+ for 300 s and stained for phos-
pho-Thr286/287-CaMKII (pCaMKII). Scale bar
represents 10 mm.
(B) Pooled data for increase in ratio of nucle-
ar:cytoplasmic pCaMKII intensities.
(C and E) Single-cell correlation of nuclear:cyto-
plasmic intensity ratio between pCaMKII and
gCaMKII (R = 0.8) or CaM and gCaMKII (R = 0.7) in
response to 40 mM K+, 300 s.
(D and F) SCG neurons expressing gCaMKII shRNA
or nonsilencing control shRNA stimulated as in (C).
Increased nuclear:cytoplasmic ratios for pCaMKII
and CaM were prevented by gCaMKII knockdown.
(G) With endogenous gCaMKII knocked down,
shRNA-resistant gCaMKIIR or gCaMKIIR T287A
were overexpressed in SCG neurons. Upon stim-
ulation as in (C), both gCaMKIIR and gCaMKIIR
T287A translocated to the nucleus; however, only
gCaMKIIR, not gCaMKIIR T287A, rescued CaM
translocation. ‘‘+’’ and ‘‘’’ indicate a significant or
insignificant change respectively (see Figures S2I
and S2J for details).
See also Figure S2.gCaMKII Needs to BeDephosphorylated byCaNnear the
Cell Surface in order to Translocate to the Nucleus
How is the nuclear translocation of gCaMKII regulated? Unlike
gCaMKII in the other tissues (Gangopadhyay et al., 2003; Take-
uchi and Fujisawa, 1998), neuronal-specific gCaMKII isoforms
(gA, gA0, and gA.B) each possess a nuclear localization signal
(NLS) (Takeuchi et al., 2002). If the NLS confers nuclear localiza-
tion, how might this be regulated? Notably, a serine (Ser334 in
gA0CaMKII) lies just C-terminal to the NLS in gCaMKII (Fig-
ure S3A); phosphorylation of a similarly positioned serine inhibits
nuclear localization in aBCaMKII and dBCaMKII (Heist et al.,
1998).
Seeking clues to such regulation, we first applied a broad
range phosphatase inhibitor, PhosSTOP (PS), and found that
PS inhibited gCaMKII translocation and pCaMKII redistribution,
without diminishing Ca2+ influx (Figure S3B–S3D). These results
implied that some kind of phosphatase activity is required for
gCaMKII translocation. gCaMKII translocation was unaffected
by okadaic acid (OA) at 2 mM, high enough to inhibit both PP1
and PP2A (Figure S3E). In contrast, gCaMKII translocation was
abolished by selective inhibition of calcineurin (CaN, also known
as PP2B), using cyclosporin A (CsA) (Figure 3A) or FK506 (Fig-
ure S3E). CsA also prevented CaM translocation and the pCREB
response (Figures 3B and 3C).284 Cell 159, 281–294, October 9, 2014 ª2014 Elsevier Inc.Cortical Neurons Also Display
CaN-Regulated Translocation of
gCaMKII and CaM
We sought next to determine whether
CaN-regulated gCaMKII translocation
exists in CNS neurons, focusing on pyra-
midal cells cultured from neocortex
where gCaMKII transcripts are promi-nent. Indeed, K+-depolarization induced nuclear translocation
of gCaMKII and CaM in cortical pyramidal neurons, but not
with Nim or CsA present (Figures 3D and 3E). To test whether
CaN participates in CaMK-dependent excitation-pCREB cou-
pling, we examined the pCREB response in cortical pyramidal
neurons with a MEK1 inhibitor (PD98059) present to avoid
engagement of the MAPK pathway (Dolmetsch et al., 2001; Wu
et al., 2001). Importantly, depolarization-triggered CREB phos-
phorylation was inhibited by CaN inhibition with CsA (Figure 3F).
Capitalizing on the abundance of cultured cortical neurons, we
isolated their nuclei and analyzed nuclear gCaMKII levels by
western blot. Consistent with immunostaining data, K+ stimula-
tion markedly elevated nuclear gCaMKII, but not with Nim pre-
sent (Figure 3G); cytoplasmic gCaMKII was, if anything, slightly
diminished (Figure S3F). Importantly, gCaMKII knockdown also
prevented CaM translocation and pCREB response (Figures
3H and 3I). Thus, CaM translocation and pCREB response in
cortical neurons depends on both CaN and gCaMKII, similar to
what we found in SCG neurons.
Dephosphorylation of Ser334 by CaN Is Critical
for gCaMKII Translocation
To identify structural determinants of the translocation, we
expressed HA-tagged gA0CaMKII protein and probed its
A B C
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Figure 3. CaN Is Necessary for gCaMKII/CaM Translocation and pCREB Response in SCG and Cortical Neurons
(A and B) SCG neurons stimulated with 40 mM K+ for 300 s in absence or presence of calcineurin-specific inhibitor cyclosporin A (CsA, 50 nm). Translocation of
both gCaMKII (A) and CaM (B) prevented by exposure to CsA.
(C) pCREB response upon 40 mM K+ stimulation for 10 s was prevented by CsA.
(D and E) Cultured cortical neurons were either mock-stimulated with 5 mM K+ or stimulated with 40 mM K+ for 60 s and stained for gCaMKII or CaM (costaining
with aCaMKII antibody to label excitatory neurons). CaV1 inhibitor Nim (10 mm) or CaN inhibitor CsA (50 nm) prevented translocation of gCaMKII and CaM.
(F) Cortical neurons treated as in (C), in additional presence of specific MEK inhibitor PD98059 (50 mm), were stained for pCREB. pCREB response inhibited
by CsA.
(G) Nuclei isolated from cultured cortical neurons and subjected to western blot analysis to probe for gCaMKII. 40 mM K+ stimulation of intact cells induced an
increase of nuclear gCaMKII that was prevented by Nim (N = 7). Lamin B is a nuclear marker.
(H) Cortical neurons transfected with either gCaMKII shRNA or nonsilencing control shRNA, stimulated as in (D) and stained for CaM. gCaMKII knockdown
prevented CaM translocation.
(I) Cortical neurons expressing either gCaMKII shRNA or a nonsilencing control shRNA. Stimulated pCREB response prevented by gCaMKII knockdown.
See also Figure S3.phosphorylation statewithmass spectrometry (LC-MS/MS) (Fig-
ures 4A and 4B). The phosphorylation status of Ser334 and other
candidate sites downstream was directly assessed. Ser334 was
phosphorylated under basal conditions in HEK293 cells (Figures
4A and 4B), whereas the level of Ser334 phosphorylation was
strongly decreased in vitro by exposure to purified CaN (Fig-
ure 4B, inset). This buttressed pharmacological evidence thatendogenous gCaMKII is a target of CaN (Figure 3A) and sup-
ported Ser334 as a site of dephosphorylation.
To mimic the negative charge that phosphorylation confers,
Ser334 of HA-tagged gA0CaMKII wasmutated toGlu (gA0, CaMKII
S334E) andmodified protein was localized with anti-HA antibody
(Figure 4C). Like endogenous gCaMKII, the HA-tagged ‘‘wild-
type’’ gA0CaMKII protein translocated to the nucleus uponCell 159, 281–294, October 9, 2014 ª2014 Elsevier Inc. 285
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Figure 4. gCAMKII Is Dephosphorylated by CaN near the Cell Surface to Drive Nuclear Translocation
(A) Full scan mass spectrum of the quintuply charged ion (m/z 564.4773) for the phosphopeptide RKS(Phospho)SSSVHLM(oxidation)EPQTTVVHNATDGIK from
gA0CaMKII.
(B) Tandem mass spectrometry (MS/MS) of the phosphopeptide RKS(Phospho)SSSVHLM(Oxidation)EPQTTVVHNATDGIK. MS/MS was performed on the
quintuply charged ion (m/z 564.4773) by using higher energy collision induced dissociation. The sequence of the peptide as well as the site of phosphorylation
were confidently identified based on the matched b- and y-ion series indicated by the spectrum annotations. Note that all b-ions except the b2 ion correspond to
fragments after neutral loss of phosphoric acid. The bar graph (insert) indicates that the phosphorylation status of S334 (marked by the orange square) was
attenuated to 50% of the control group after adding calcineurin and CaM for 30 min. N = 3 experiments, each done in triplicate.
(C) SCG neurons expressing gA0CaMKII or gA0CaMKII S334E stimulated with 40 mM K
+ for 300 s; gA0but not gA0S334E translocated to the nucleus upon stim-
ulation. Puncta of gA0CaMKII S334E formed on the cell surface upon stimulation marked by green arrows. Scale bar represents 10 mm. Inset, position of S334E
point mutation, just carboxyl to the nuclear localization sequence (NLS).
(D and E) Representative images of SCG neurons overexpressing gA0CaMKII S334E or gA0CaMKII, stimulated with 40 mM K
+ for 60 s. Arrowheads, sites where
gA’CaMKII S334E puncta colocalize with CaN (D) or gA0puncta colocalize with CaN in presence of CaN inhibitor CsA (lower panel) (E). No gA0CAMKII puncta
formed without CaN inhibitor (upper panel) (E). Scale bar represents 5 mm.
See also Figure S4.40 mM K+ stimulation (Figures 4C, left, and S4A), an event pre-
vented by Nim, CsA or FK506 (Figure S4B). In contrast, the phos-
phomimetic gA0CaMKII S334E protein was mostly cytoplasmic
under basal conditions and failed to undergo translocation
upon stimulation (Figure 4C, right). Thus, dephosphorylation of286 Cell 159, 281–294, October 9, 2014 ª2014 Elsevier Inc.Ser334 of gCaMKII appears necessary for its nuclear
translocation.
While failing to translocate to the nucleus, gA0CaMKII S334E
nonetheless underwent redistribution, forming puncta near the
surfacemembrane upon depolarization (Figure 4D). Such puncta
were not seen with gA0CaMKII itself (Figure 4E, upper row) unless
CaN was inhibited with CsA (Figure 4E, lower row). Evidently, in-
hibition of dephosphorylation, by phosphomimetic mutation or
CaN inhibition, creates a biochemical bottleneck, causing gA0
CaMKII to pile up. The puncta mark sites where CaN-mediated
dephosphorylation would normally initiate translocation to the
nucleus. Indeed, puncta of gA0CaMKII S334E coincided with
puncta of CaN (Figure 4D, merged image). Similar colocalization
was seen in multiple planes of focus (Figure S4C). gA0CaMKII
puncta also colocalized with CaN when CaN was inhibited with
CsA (Figure 4E, bottom row). CaN puncta appeared no different
when phosphatase activity was not inhibited (Figure 4E, top row).
Without an imposed bottleneck, the lack of gA0CaMKII puncta
can be attributed to prompt CaN-triggered translocation to the
nucleus.
gCaMKII Travels to a Signaling Checkpoint in a
CaM-Bound, but Not a Thr287-Phosphorylated, Form
We next focused on how gCaMKII is recruited to these signaling
checkpoints. The puncta formed by gA0CaMKII S334E provided
an assay of biochemical steps preceding its arrival at the check-
point. Consistent with previous reports (Shen and Meyer, 1999),
CaMbinding to gCaMKII was necessary to enable its recruitment
to surface sites (see Figures S4D–S4I and legends for details). At
what subsequent stage is gCaMKII phosphorylated for sake of
CaM trapping? A gA0CaMKII construct with a phosphomimetic
T287E mutation remained dispersed within the cytosol after
stimulation (Figures S4J1 and S4J3). Similarly, a doubly altered
gA0CaMKII T287E, S334E construct failed to form puncta upon
stimulation (Figures S4J2 and S4J4). Evidently, gCaMKII cannot
be mobilized from the cytosol and targeted to the cell surface
when Thr287 is fully phosphorylated (Hudmon et al., 2005;
Shen and Meyer, 1999). Thus, it is CaM-bound, but not fully
Thr287-phosphorylated gCaMKII that is recruited to the CaV1
checkpoints (Figure S4M). Such phosphorylation likely occurs
before translocation to the nucleus because expression of the
nuclear translocation-defective gA0CaMKII S334E strongly
increased pCaMKII levels in the cytoplasm and at surface puncta
(Figures S4K and S4L). Thus, Thr287 phosphorylation of gCaM-
KII likely occurs after its mobilization from the cytosol, but before
dephosphorylation of Ser334.
bCaMKII Is Dispensable for gCaMKII Translocation
but Is Required for Nuclear Accumulation of pCaMKII
and CaM
Upon stimulation, CaMKII isoforms other than gCaMKII, princi-
pally bCaMKII in cultured SCG neurons, congregate at surface
puncta and help initiate signaling to the nucleus (Wheeler et al.,
2012). Although bCaMKII does not translocate to the nucleus
(Figure S1B), its aggregation suits the role of phosphorylating
gCaMKII to enable the CaM trapping in two key respects: spe-
cific localization and activity. First, bCaMKII puncta coincided
with CaV1 channel puncta (Wheeler et al., 2012) (Figure 5A);
gCaMKII was alsomobilized to CaV1 channels, judging by coloc-
alization of gA0CaMKII S334E puncta with CaV1 channel puncta
(Figure 5B). Second, the clusters of bCaMKII appeared to be
activated, insofar as they coincided with puncta of pCaMKII
(Wheeler et al., 2012), not attributable to gCaMKII (Figures 4C,left, and 4E, top). Thus, bCaMKII clusters appear well-suited to
drive Thr287 phosphorylation of gCaMKII.
To test this, we knocked down bCaMKII with an shRNA
construct that reduced bCaMKII mRNA levels by 90% while
leaving gCaMKII transcripts unchanged (Wheeler et al., 2008).
The distributions of pCaMKII, gCaMKII, and CaMwere monitored
in cells infected with the knockdown construct or a nonsilencing
control (Figure 5C). Knockdown of bCaMKII largely abolished
the K+-induced increase in nuclear pCaMKII (Figure 5C, top
row), but spared the nuclear gCaMKII rise (Figure 5C, second
row). bCaMKII knockdownalso preventedCaM translocation (Fig-
ure 5C, third row), reminiscent of the pattern seen with gCaMKII
T287A (Figures 2G, right, S2I, and S2J, right). Finally, knocking
down bCaMKII also prevented CREB phosphorylation (Figure 5C,
bottom row) (Wheeler et al., 2012). These observations were
corroborated in pooled data (Figures S5A–S5D). Evidently,
without bCaMKII-dependent phosphorylation at T287, nuclear
translocation of the gCaMKII shuttle occurs without cargo and
CREB activation fails. Critically, bCaMKII shRNA resistant bCaM-
KIIR (Figure S5E) rescued the nuclear increase in pCaMKII, CaM
translocation and pCREB response (Figure S5F–S5H), without
affecting gCaMKII nuclear translocation (Figure S5I). These obser-
vations supported the idea that bCaMKII phosphorylatesgCaMKII
at Thr287 at the surface checkpoint, stabilizes the gCaMKII-CaM
complex, and thus ensures proper cotransport of Ca2+/CaM to the
nucleus along with gCaMKII. Nuclear delivery of gCaMKII is not
sufficient by itself to trigger a pCREB response; cotransfer of
Ca2+/CaM is required.
The canonical mechanism of Thr286/287 phosphorylation, an
intersubunit, intraholoenzyme reaction, was first revealed at
low concentrations of CaMKII holoenzyme. However, interho-
loenzyme phosphorylation might occur in the concentrated envi-
ronment of a CaV1-centered signaling nanodomain. To test for
interholoenzyme phosphorylation, we set up an enriched envi-
ronment in vitro. The test substrate, immobilized on beads,
was a gCaMKII variant that can bind CaM but is catalytically
inactive (K43R). Thr287 phosphorylation of bead-concentrated
gCaMKII K43R was significantly increased by purified bCaMKII
when activated by Ca2+/CaM (Figures 5D and 5E). Thus, inter-
molecular phosphorylation can occur if bCaMKII and gCaMKII
are colocalized in a high concentration environment.
We also tested another scenario wherein endogenous
bCaMKII and gCaMKII basally coassemble into heteromultimers
and travel together to the CaV1 checkpoint and then to the nu-
cleus. In contradiction, formation of near-surface puncta of
bCaMKII (Figure 5F) was not accompanied by detectable puncta
of gCaMKII (Figure 5G); gCaMKII S334E puncta verified our abil-
ity to detect puncta of gCaMKII (Figure 5H). Furthermore, no in-
crease in nuclear bCaMKII was detected, despite clear rises in
nuclear gCaMKII (Figures S1B and 1A). Thus, cotranslocation
of fixed heteromultimers of bCaMKII and gCaMKII was not sup-
ported. We further considered the idea that basal coassembly of
bCaMKII and gCaMKII might give way at the checkpoint to auto-
phosphorylation-dependent subunit exchange (Stratton et al.,
2014); bCaMKII could conceivably be stranded at the checkpoint
while newly assembled gCaMKII homomultimers traveled on-
ward to the nucleus. Against this scenario, subunit exchange re-
quires autophosphorylation of T305/T306, key residues withinCell 159, 281–294, October 9, 2014 ª2014 Elsevier Inc. 287
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(A and B) Arrowheads, sites where endogenous bCaMKII (A) or overexpressed gA0CaMKII S334E (B) colocalize with puncta of CaV1.3 channels upon 40 mM K
+
stimulation for 60 s. Scale bar represents 1 mm.
(C) SCG neurons expressing bCaMKII shRNA or nonsilencing control shRNA were stimulated with 40 mM K+ for 300 s and stained for pCaMKII (first row),
costained for gCaMKII and CaM (second and third row), stained for pCREB (fourth row). Scale bar represents 10 mm. bCaMKII knockdown prevented the increase
in nuclear pCaMKII levels (), CaM translocation () and pCREB response (), but did not affect gCaMKII translocation (+). ‘‘+’’ and ‘‘’’ indicate a significant or
insignificant change respectively (see Figures S5A–S5D for details).
(legend continued on next page)
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Figure 6. Activation of Nuclear CaMK Cascade and Distinct Roles of gCaMKII and CaM in Driving CREB Phosphorylation
(A) SCG neurons stimulated with 40mMK+ for 10 s in the absence or presence of CaN inhibitor CsA (50 nm). Increase in nuclear pCaMKIV levels inhibited by CsA.
(B) SCG neurons expressing gCaMKII shRNA, bCaMKII shRNA or nonsilencing control shRNA were stimulated with 40 mM K+ for 10 s and stained for pCaMKIV.
Knockdown of gCaMKII or bCaMKII prevented the activation of CaMKIV.
(C) Schema showing free Ca2+/CaM (denoted CaM*) delivered by gCaMKII activating the CaMK cascade comprised of CaMKK andCaMKIV. Prevention of critical
steps by applying different inhibitors (CsA, STO-609) or shRNA (against bCaMKII, gCaMKII or CaMKIV) indicated in red; rectangles showmonitored variables (see
Figure S6 for details).
(D–F) SCG neurons expressing gCaMKII shRNA with gCaMKII shRNA-resistant gA0CaMKII
R or gA0K43R were stimulated with 40 mMK
+ for 300 s (D and E) or 10 s
(F). Both gA0CaMKII
R and gA0CaMKII
R K43R can translocate to the nucleus upon the stimulation (D), and support CaM translocation (E) and pCREB response (F).
(G) SCG neurons expressing gCaMKII shRNAwith gCaMKII shRNA resistant gA0A303R or gA0CaMKII
R T287Awere stimulated as in (F). Neither gA0CaMKII
R A303R
nor gA0CaMKII
R T287A rescued the pCREB response.
See also Figure S6.the CaM footprint (Stratton et al., 2014); such autophosphoryla-
tion is mutually exclusive with Ca2+/CaM binding and thus pro-
hibited during continuous Ca2+ elevation (Figures 1 and S1L).
Even if heteromultimers of gCaMKII and bCaMKII form, they
are unlikely to dominate gCaMKII mobilization to either the sur-
face membrane or the nucleus.
The gCaMKII-CaM Shuttle Activates a Nuclear CaM
Kinase Cascade
What happens once the gCaMKII-Ca2+/CaM complex arrives in
the nucleus? We tested for signaling by a well-characterized nu-
clear ‘‘CaM kinase cascade’’ (Figures 6A–6C) (Means, 2000; So-
derling, 1999). Nuclear-resident CaMKIV is thought to be critical
for triggering CREB phosphorylation (Bito et al., 1996; Means,
2000; Soderling, 1999). CaMKIV becomes activated via Thr196
phosphorylation by CaM kinase kinase (CaMKK) (Selbert et al.,
1995). The role of this cascade was probed by pharmacological(D and E) HA-tagged gA0CaMKII K43R was concentrated and immobilized with ag
or without the presence of 44 mg/ml bCaMKII, 1 mMCaCl2 and 1 mMCaM, the imm
blot analysis. Phosphorylation state and amount of gA’CaMKII K43R detected by
bCaMKII was used to confirm that the pCaMKII was not caused by bCaMKII accu
the presence of bCaMKII (n = 7), but only if both CaM and Ca2+ were present (n
(F–H) Arrowheads indicate sites where endogenous bCAMKII (F) and overexpress
upon 40 mM K+ stimulation for 60 s. Scale bar represents 1 mm.
See also Figure S5.and molecular interventions and by monitoring phosphorylation
of CaMKIV and CREB (shown in red in Figure 6C). CaMKIV
was concentrated in the nucleus in SCG neurons and did not
redistribute upon depolarization (Figures S6A and S6C). Its
phosphorylation, assessed with an antibody against phospho-
Thr196 CaMKIV (pCaMKIV) (Selbert et al., 1995), increased
3-fold upon K+-depolarization (Figures S6A and S6B). Knock-
down of CaMKIV by shRNA (near-complete loss of protein; Fig-
ure S6D) abolished the depolarization-dependent increase in
pCREB (Figure S6E). The specific CaMKK inhibitor STO-609 pre-
vented the increases in nuclear pCaMKIV (Figure S6F) and
pCREB (Figure S6G), confirming the Involvement of CaMKK.
These data show that SCG neurons rely on activation of CaMKK
and CaMKIV for CREB phosphorylation.
Is cotranslocation of gCaMKII/CaM necessary for activation of
the CaMKK-CaMKIV cascade? Activation of CaMKIV was
indeed prevented (1) by exposure to CsA to prevent gCaMKIIarose beads coated with HA antibody. After a 10 s exposure to 25 mMATP, with
obilized gA0CaMKII K43R was eluted from the beads and collected for western
specific antibodies against pCaMKII and gCaMKII (D). A specific antibody to
mulation on the beads. (E) Ratio of pCaMKII: gCaMKII increased significantly in
= 4).
ed gA0CaMKII S334E (G), but not gCaMKII (H), colocalize with pCaMKII puncta
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(A) Testing the sufficiency of Ca2+/CaM with a
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successfully targeted to the nucleus. Scale bar
represents 10 mm.
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S36D was able to restore the pCREB response,
consistent respectively with the ability or inability
to harbor CaM for release upon nuclear Ca2+
elevation. Under basal conditions, overexpressing
NLS-Nrgn or NLS-Nrgn S36D did not affect
pCREB levels (see Figures S7A and S7B for
details).
See also Figure S7.and CaM translocation (Figure 6A), (2) by shRNA knockdown of
gCaMKII (Figure 6B), and (3) by bCaMKII knockdown (Figure 6B).
These findings account for the inhibition of CREB phosphoryla-
tion by the same maneuvers. Activation of the nuclear CaMK
cascade is the critical intermediary between gCaMKII-CaM
cotransport to the nucleus and activation of CREB.
gCaMKII Catalytic Activity Is Not Necessary for CREB
Phosphorylation
Does gCaMKII operates as a protein kinase or merely as a trans-
porter of Ca2+/CaM? To answer this, we knocked down endog-
enous gCaMKII with gCaMKII shRNA and compared the effects
of shRNA-resistant rescue constructs, gA0CaMKII
R and gA0
CaMKIIR K43R (kinase dead). The catalytically inactive protein
still translocated to the nucleus (Figure 6D), rescued CaM trans-
location (Figure 6E), and supported the pCREB response (Fig-
ure 6F), each to the same extent as kinase active gA0CaMKII
R.
In sharp contrast, attempted rescue by expression of gA0
CaMKIIR A303R or gA0CaMKII
R T287A failed to support pCREB
response (Figure 6G), consistent with the inability of these vari-
ants to support respectively CaM binding or sequestration, and
hence CaM translocation (Figures S2I and S4F). Indeed, inhibit-
ing nuclear CaM untrapping from gCaMKII also prevented the
pCREB response, as tested by blocking PP2A dephosphoryla-
tion of phospho-gCaMKII (see Figures S6H and S6I and legend
for details). Taken together, our results indicated that nuclear
Ca2+/CaM, not the catalytic activity of gCaMKII, is necessary
for triggering CREB phosphorylation.
Sufficiency of Nuclear CaM Delivery in the Absence of
gCaMKII Translocation
Given the necessity of nuclear CaM delivery, over and above
elevation of gCaMKII, we asked whether delivery of CaMnuc is290 Cell 159, 281–294, October 9, 2014 ª2014 Elsevier Inc.also sufficient, even without gCaMKII.
Nuclear liberation of CaM was accom-
plished by exploiting neurogranin (Nrgn),
an endogenous CaM buffer that seques-
ters apoCaM but releases CaM once it
becomes Ca2+ bound (Baudier et al.,1991). By fusing Nrgn with an N-terminal NLS, we targeted
NLS-Nrgn (and thus ‘‘caged CaM’’) to the nucleus of quiescent
SCG neurons (Figures 7A and 7B). Expression of this construct
had no effect on CREB phosphorylation without stimulation (Fig-
ures S7A and S7B) and slightly increased the pCREB response
(p < 0.03) to depolarization (Figures 7C and S7B, left bars). In
the test of sufficiency, we examined the effect of NLS-Nrgn
following gCaMKII knockdown to eliminate normal cytoplasm-
to-nucleus shuttling of CaM (Figure 2F). Blockade of this route
of CaM delivery verifiably prevented CREB phosphorylation in
40 K+. In sharp contrast, the pCREB response was restored to
normal levels (p = 0.8) by the NLS-Nrgn construct (Figures 7C
and S7B, right bars). To establish that nuclear Nrgn acts to
liberate Ca2+/CaM, we tested an S36D variant of NLS-Nrgn,
which lacks apoCaM binding; NLS-Nrgn S36D failed to rescue
CREB phosphorylation (Figures 7C and S7B, right bars). Finally,
the CaMKK inhibitor STO-609 abolished the NLS-Nrgn-rescued
pCREB response (Figure S7C), confirming that the uncaged
Ca2+/CaM operates via the nuclear CaMK cascade. This set of
NLS-Nrgn experiments demonstrated that direct delivery of nu-
clear Ca2+/CaM is sufficient to drive nuclear CREB phosphoryla-
tion if the normal shuttling of CaM is disabled. Thus, nuclear
Ca2+/CaM is both necessary and sufficient to support this form
of E-T coupling.
DISCUSSION
Our experiments demonstrate a mechanism for transmitting
information within cells: shuttling Ca2+/CaM from one location to
another. gCaMKII, largely overlooked in neuroscience since its
discovery 25 years ago (Tobimatsu et al., 1988), is identified
hereas thesurface-to-nucleusshuttle in sympathetic andneocor-
tical pyramidal neurons. The shuttle works as follows: Neuronal
membrane depolarization opens CaV1 channels that deliver Ca
2+
to the cytoplasm and promote binding of Ca2+/CaM to gCaMKII.
The Ca2+/CaM-gCaMKII complex is recruited to CaV1 channels
where another isoform of CaMKII (bCaMKII in sympathetic
neurons, a, bCaMKII in cortical neurons) also clusters. Two regu-
latory events ensue: the phosphorylation of gCaMKII at T287 by
bCaMKII, trapping the Ca2+/CaM cargo, and the CaN-mediated
dephosphorylation of gCaMKII at S334, enabling an adjacent
NLS to direct the loaded shuttle to the nucleus. Nuclear delivery
of Ca2+/CaM activates the nuclear CaMK cascade, thus driving
CREBphosphorylation and transcription of CRE-regulated genes
(Graphical Abstract).
Clarifying How Ca2+/CaM Translocation Serves as a
Long-Range Communication Mechanism
CaM movements from cytoplasm to nucleus upon elevation of
[Ca2+]cyto have previously been reported in neurons (Deisseroth
et al., 1998), mammalian cell lines (Teruel et al., 2000; Thorogate
and To¨ro¨k, 2004), and heart cells (Wu and Bers, 2007). Skepti-
cism about the functional relevance of these observations has
persisted (Hagenston and Bading, 2011; Hardingham et al.,
2001). The abundance of nuclear CaM may seem to obviate
any need for CaM translocation. However, nuclear free CaM is
in short supply (Teruel et al., 2000) because of the abundance
of nuclear CaM-binding proteins (Bachs et al., 1994), leaving op-
portunity for freshly imported Ca2+/CaM to drive further signaling
(Teruel et al., 2000). Another concern is the putatively rapid
dissociation of Ca2+ from CaM once [Ca2+]free begins to fall. It
has been unclear how CaM, lacking an NLS, might travel to the
nucleus other than by passive diffusion (Thorogate and To¨ro¨k,
2004). We proposed that Ca2+/CaM stabilization and nuclear tar-
geting could both arise from binding to a CaMK, but were unable
to find such a partner (Deisseroth et al., 1998; Mermelstein et al.,
2001). These issues are now resolved by the identification of
gCaMKII as the long-sought molecular shuttle.
Functional Rationale of CaM-Driven Signaling
The shuttle mechanism helps clarify the functional logic of exci-
tation-pCREB coupling. Clusters of CaV1 channels provide a
nucleation point for participants in surface-to-nucleus communi-
cation, including CaN and bCaMKII (Wheeler et al., 2008, 2012),
thus illuminating the long-observed reliance of E-T coupling on
CaV1 channels (Deisseroth et al., 1996; Greenberg et al., 1986;
Murphy et al., 1991; Wheeler et al., 2012). The joint involvement
of bCaMKII and calcineurin accounts for previously puzzling
findings that CaM kinase and CaN work synergistically rather
than in opposition to promote CREB phosphorylation (Hahm
et al., 2003) and CRE-mediated gene expression (Kingsbury
et al., 2007; Schwaninger et al., 1995). The localization of mul-
tiple signaling events within the nanodomain of CaV1 channels
accounts for differential effects of fast and slow on-rate Ca2+
buffers (BAPTA, EGTA) in preventing CaMKII relocation (Wheeler
et al., 2012) and CREB phosphorylation (Deisseroth et al., 1996).
Launching the signaling at a CaV1-centered Ca
2+ nanodomain
frees up separate clusters of CaV2 channels for other functions
such as signaling to ER and mitochondria (Wheeler et al.,
2012). By temporarily trapping Ca2+/CaM, a shuttle mechanism
can go on signaling even after rises in cytosolic Ca2+ have sub-sided, thus reducing the duration of Ca2+ elevation needed to
trigger a response.Whether similar ‘‘private line’’ communication
also holds for the wide array of Ca2+ entry and release pathways
within cells (Berridge, 2012; Clapham, 2007) requires further
investigation.
Our experiments indicate that gCaMKII serves to sequester
and convey Ca2+/CaM, and its kinase activity is dispensable
for driving CREB phosphorylation. Progressive accumulation of
nuclear Ca2+/CaM provides a means for integrating the effects
of multiple weak stimuli (Mermelstein et al., 2001). Because
CaMKK and CaMKIV both require Ca2+/CaM binding to drive
CaMKIV activation (Means, 2000; Wayman et al., 2008), CREB
phosphorylation should increase in a steep power law relation-
ship with D[Ca2+/CaM]nuc, consistent with our data. Activation
of nuclear CaMKIV has multiple regulatory effects beyond
CREB phosphorylation. CaMKIV-mediated phosphorylation ac-
tivates CREB binding protein (CPB) (Impey et al., 2002), an
important cofactor of CREB, CREST and other transcription fac-
tors. CBP also regulates the nuclear localization of certain his-
tone deacetylases (McKinsey et al., 2000). Furthermore, CaMKIV
helps control alternative splicing of pre-mRNA (Xie and Black,
2001). Thus, by clarifying how nuclear CaMKIV becomes
activated, our findings help explain the dominant role of CaV1
channels in phenomena ranging from activation of CBP to his-
tone deacetylation and exon selection.
Higher-Order Significance and Distinctions from
Other Pathways
The importance of nuclear CaM for brain function has been
shown with a nucleus-localized trap that curbs rises in nuclear
Ca2+/CaM while sparing cytosolic CaM signaling. This inhibited
CREB phosphorylation, curbed L-LTP, and abrogated spatial
memory (Limba¨ck-Stokin et al., 2004); thus functional con-
sequences of thwarting the Ca2+/CaM shuttle were elegantly
revealed. This CaM/CaMK-based system adds to known mech-
anisms for signaling between neuronal (e.g., postsynaptic) mem-
brane and nucleus (Ch’ng and Martin, 2011; Hagenston and
Bading, 2011; Jordan and Kreutz, 2009; Saha and Dudek,
2008). The present mechanism likely tracks neuronal depola-
rization rather than synaptic activity per se, as is likely for the
NMDAR-driven transcription factors NFkB (Meffert et al.,
2003), Jacob (Karpova et al., 2013) and CRTC1/TORC1 (Ch’ng
et al., 2012). These systems may link specific inputs to a
restricted set of transcriptional events. In contrast, translocation
of Ca2+/CaM and activation of CaMKIV may achieve a broader
impact because of the multiplicity of CaMKIV actions. Of known
pathways, the CaM kinase-basedmechanism is quickest to acti-
vate and most sensitive to brief, weak stimuli; even 50 spikes will
trigger a 50% activation of CREB over basal levels (Wheeler
et al., 2012). Thus, the shuttle mechanism may be tuned for effi-
cacy, speed and sensitivity.
Implications for Schizophrenia, Autism, and Other
Neuropsychiatric Disorders
Several proteins in the shuttle pathway (subunits of CaV1 chan-
nels, gCaMKII, bCaMKII, and CaN) are encoded by genes asso-
ciated with major neuropsychiatric disorders (autism spectrum
disorder [ASD], schizophrenia [SCZ], major depressive disorderCell 159, 281–294, October 9, 2014 ª2014 Elsevier Inc. 291
[MDD], and bipolar disorder [BPD]) (Table S1; Supplemental In-
formation). Further study is needed to determine which genetic
modifications are causal. Already, the extensive representation
of the signaling components described here supports the notion
that altered activity-dependent regulation of nuclear events
may be a general hallmark of mental disorders. For example,
CaMK2G, the gene for gCaMKII, crops up repeatedly in neuro-
psychiatric studies. A polymorphism in CaMK2G is strongly
related to variability in humanmemory performance (deQuervain
and Papassotiropoulos, 2006). Protein levels of gCaMKII (and
of bCaMKII) appear significantly elevated in the lateral habenulae
of rat models of MDD (Li et al., 2013). Likewise, the abundance of
gCaMKII protein is increased in NMDAR-related mouse models
of schizophrenia (Table S1) (Kocerha et al., 2009). Finally,
CaMK2G is a member of a cluster of genes (M12) that has
been implicated in autism by transcriptome analysis of autistic
brains. Alternative splicing of CaMK2G is sharply altered in
ASD samples (Voineagu et al., 2011); this occurs in association
with dysregulation of A2BP1, a splicing factor regulated by CaM-
KIV (Xie and Black, 2001). Thus, our findings could be relevant to
brain disorders in multiple ways: by identification of signaling
molecules that support CaMKIV-driven alternative splicing as
well as activity-dependent transcription.
EXPERIMENTAL PROCEDURES
Additional information regarding primary cultures, plasmids, buffers, anti-
bodies, primer sequences, sample preparation, mass spectrometry analysis,
and detailed procedures is provided in the Extended Experimental Procedures.
Primary Neuronal Cultures
SCG neurons or cortical neurons were cultured as previously described
(Wheeler et al., 2008, 2012), with minor modifications (see Extended Experi-
mental Procedures).
Drug Treatments and Stimulation
We stimulated SCGor cortical neuronswith the indicated K solution at 37C for
10–300 s before fixation (see Extended Experimental Procedures).
Lentiviral Transduction of SCG Neurons
Lentiviral constructs were made with psPAX2 and pMD2.g. Lentivirus was
added to SCG cultures 1 day after plating, using GFP expression to monitor
infection (see Extended Experimental Procedures).
Image Analysis
Images for pCREB quantification and puncta weight were analyzed as previ-
ously described (Wheeler et al., 2012).
Immunoprecipitation
Pierce Classic IP Kit (Thermo Fisher) was used to concentrate gA0CaMKII K43R
on agarose beads, the degree of phosphorylation, and the total amount of gA0
CaMKII K43R was determined by western blot.
Statistical Analysis
All the data were normalized to corresponding basal conditions. Without
further indication, quantification was based onR24 fields under a 633 objec-
tive from three to six platings per condition.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at http://dx.doi.
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